The FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy. CureDuchenne provided early funding to Sarepta Therapeutics for the development of this drug. This provides hope to all Duchenne families and this is a huge step forward in turning Duchenne from a fatal disease to a more manageable condition. We need to continue to fund research until there is a cure for all those with Duchenne. For more information go to www.CureDuchenne.org
